BET-IN-21 is a selective BET inhibitor targeting the extra terminal domain, demonstrating a Ki of 230 nM. This compound effectively inhibits microglial activation and exhibits therapeutic benefits in models of experimental autoimmune encephalomyelitis. It serves as a valuable tool for research into neuroinflammation and related neurodegenerative disorders.
BET-IN-21 is a selective BET inhibitor targeting the extra terminal domain, demonstrating a Ki of 230 nM. This compound effectively inhibits microglial activation and exhibits therapeutic benefits in models of experimental autoimmune encephalomyelitis. It serves as a valuable tool for research into neuroinflammation and related neurodegenerative disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: